NASDAQ: ASPIAsp Isotopes Inc Stock
$1.99-0.04 (-1.97%)
Updated Nov 28, 2023
ASPI Price
$1.99
Fair Value Price
N/A
Market Cap
$97.06M
52 Week Low
$0.28
52 Week High
$2.30
P/E
-4.42x
P/B
11.23x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$13.43M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.37
Operating Cash Flow
-$4M
Beta
0.13
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ASPI Overview
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
Zen Score
–
Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ASPI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ASPI is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ASPI is poor value based on its book value relative to its share price (11.23x), compared to the US Chemicals industry average (1.69x)
P/B vs Industry Valuation
ASPI is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ASPI due diligence checks available for Premium users.
Be the first to know about important ASPI news, forecast changes, insider trades & much more!
ASPI News
Valuation
ASPI fair value
Fair Value of ASPI stock based on Discounted Cash Flow (DCF)
Price
$1.99
Fair Value
$1.17
Overvalued by
69.51%
ASPI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
ASPI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-4.42x
Industry
17.54x
Market
32.56x
ASPI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
11.23x
Industry
1.69x
ASPI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ASPI's financial health
Profit margin
Revenue
$0.0
Net Income
-$4.2M
Profit Margin
0%
ASPI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$11.9M
Liabilities
$3.2M
Debt to equity
0.37
ASPI's short-term assets ($2.73M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASPI's short-term assets ($2.73M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASPI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$653.3k
Investing
-$681.6k
Financing
$0.0
ASPI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ASPI vs Chemical Stocks
Asp Isotopes Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.